PL
DMAQR

Parkwood LLC’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Parkwood LLC’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-157,100
Closed -$47K – 208
2023
Q4 		$47K Hold
157,100
– – 0.01% 125
2023
Q3 		$55K Hold
157,100
– – 0.01% 134
2023
Q2 		$22K Hold
157,100
– – ﹤0.01% 133
2023
Q1 		$23K Hold
157,100
– – ﹤0.01% 148
2022
Q4 		$9K Hold
157,100
– – ﹤0.01% 154
2022
Q3 		$6K Buy
157,100
+131,700
+519% +$14.6K ﹤0.01% 157
2022
Q2 		$3K Buy
+25,400
New +$4.13K ﹤0.01% 153

Parkwood LLC's DMAQR Position: Q1 2024 in Review

Parkwood LLC sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 157,100 shares — an estimated $47K sold.

Parkwood LLC first reported a position in DMAQR in Q2 2022 and held it in 7 quarters. The position peaked at $55K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

  • Parkwood LLC reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
  • Parkwood LLC sold 157,100 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $47K.
  • Parkwood LLC first reported a position in Deep Medicine Acquisition Corp. Rights in Q2 2022 and held it in 7 quarters.
  • Parkwood LLC's Deep Medicine Acquisition Corp. Rights position peaked at $55K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Parkwood LLC's 13F filing for Q1 2024, filed 15 May 2024.